San Diego, CA -- (SBWIRE) -- 01/31/2019 -- An investor, who purchased shares of Alkermes Plc (NASDAQ: ALKS), filed a lawsuit in the U.S. over alleged Securities Laws violations by Alkermes Plc in connection with certain allegedly false and misleading statements.

Investors in purchased shares of Alkermes Plc (NASDAQ: ALKS) have certain options and for certain investors are short and strict deadlines running. Deadline: February 25, 2019. NASDAQ: ALKS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint the plaintiff alleges on behalf of purchasers of Alkermes Plc (NASDAQ: ALKS) common shares between February 17, 2017 through November 1, 2018, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 17, 2017 through November 1, 2018, the , defendants made false and/or misleading statements and/or failed to disclose that the U.S. Food and Drug Administration ("FDA") had advised Alkermes to follow a certain protocol in connection with its New Drug Application submission for ALKS 5461, that Alkermes had failed to follow that protocol, that consequently, an FDA advisory committee voted 21 to 2 against the approval of ALKS 5461; and that as a result, Alkermes' public statements were materially false and/or misleading at all relevant times.

Those who purchased shares of Alkermes Plc (NASDAQ: ALKS) have certain options and should contact the Shareholders Foundation.

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com